Skip to main content
Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
1.380
+0.030 (2.22%)
Dec 20, 2024, 4:00 PM EST - Market closed

Aytu BioPharma Revenue

Aytu BioPharma had revenue of $16.57M in the quarter ending September 30, 2024, a decrease of -6.98%. This brings the company's revenue in the last twelve months to $79.76M, down -18.25% year-over-year. In the fiscal year ending June 30, 2024, Aytu BioPharma had annual revenue of $81.00M, down -24.58%.

Revenue (ttm)
$79.76M
Revenue Growth
-18.25%
P/S Ratio
0.10
Revenue / Employee
$781,951
Employees
102
Market Cap
8.49M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 202481.00M-26.40M-24.58%
Jun 30, 2023107.40M10.73M11.10%
Jun 30, 202296.67M31.04M47.29%
Jun 30, 202165.63M38.00M137.52%
Jun 30, 202027.63M20.31M277.47%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Dominari Holdings 12.59M
Evogene 7.48M
COSCIENS Biopharma 4.83M
QT Imaging Holdings 4.04M
RedHill Biopharma 3.71M
Virax Biolabs Group 84.87K
BioCardia 71.00K
Revenue Rankings

AYTU News

More News